Research featured on news and major funding boost to advance gene therapy to stimulate retinal regeneration

A/Prof Raymond Wong and Mirugen Pty Ltd were awarded $1.92 million funding support from the Medical Research Future Fund (MRFF) CUREator+ grant to advance commercial development of a gene therapy using cell reprogramming to stimulate retina regeneration. This research would potentially offer a novel treatment to restore vision in patients suffering from a number of retinal degenerative diseases.

Read the online news coverage here:

• Media release by Office of Minister for Health and Aged Care [Link]

• Media release by Brandon Biocatalyst [Link]

• Media release by Centre for Eye Research Australia [Link]

• Retina UK [Link]

• Insight news [Link]

• ANDHealth news [Link]

• Mivision the ophthalmic journal [Link]

• Eyesmart news [Link]

• University of Melbourne - Enterprising Melbourne [Link]